Supporting HIV care through education and innovation

New CAREAction: HIV-Associated Neurocognitive Disorders and Combination Antiretroviral Therapy

New CAREAction: HIV-Associated Neurocognitive Disorders and Combination Antiretroviral Therapy

Monday, July 14, 2014
HRSA HIV/AIDS Bureau

HRSACareActionJuly2014The July 2014 issue of HRSA CAREAction focuses on HIV-associated neurocognitive disorders and combination antiretroviral therapy. Highly active antiretroviral therapy (HAART) has dramatically decreased incidence of HIV-associated dementia (HAD), the most severe form of HIV-associated neurocognitive disorder (HAND).

As people living with HIV (PLWH) age, they become more vulnerable to HAND, although it can also occur in younger people too. While there is currently no cure for HAND, there have been strides in this field.

HRSA/HAB is dedicated to addressing the mental health needs of Ryan White Program patients, and increasing awareness of HAND is just one more way to do so.

See the Mental Health topic page for more resources.

Add a Comment

Log in or register to post comments